Talyst names new CEO
Ms Corkern has been with the company for two years, serving as COO, then interim CEO. She also serves on Talyst’s board of directors. She has more than
Novartis has signed an agreement to purchase Myricx Bio, a UK-based biotechnology company, in a transaction valued at up to $1.5bn.
Novavax said that the vaccine, which does not contain an adjuvant, induced robust neutralizing antibody responses. Novavax’s virus-like particle (VLP) candidate is directed against the H5N1 A/Indonesia/05/2005 avian